RETINAL | Retinal imaging prevention and early detection of chronic diseases

Summary
The overall objective of the RETINAL initiative of ULMA Embedded Solutions is to develop non-invasive and cost-effective tools with capacity for prevention and/or early detection of various diseases related to NCD complications, by analyzing the changes in the microvasculature of the retina.The basic framework of RETINAL is a comprehensive solution for ophthalmic imaging analysis and treatment composed of a simple, reliable and cost-effective color fundus digital image capture device and several specific software modules associated to the device for a number of specific clinical applications.The goal of this action is to demonstrate in the market, by independent peers, that RETINAL is the best available and cost-effective technology for the detection of diabetic retinopathy in DR Screening Programmes, and particularly valuable for its implementation at primary health centres, which makes screening more accessible to patients and therefore more effectiveThe overall objective of the RETINAL initiative of ULMA Embedded Solutions is to develop non-invasive and cost-effective tools with capacity for prevention and/or early detection of various diseases related to NCD complications, by analyzing the changes in the microvasculature of the retina.The basic framework of RETINAL is a comprehensive solution for ophthalmic imaging analysis and treatment composed of a simple, reliable and cost-effective color fundus digital image capture device and several specific software modules associated to the device for a number of specific clinical applications.The goal of this action is to demonstrate in the market, by independent peers, that RETINAL is the best available and cost-effective technology for the detection of diabetic retinopathy in DR Screening Programmes, and particularly valuable for its implementation at primary health centres, which makes screening more accessible to patients and therefore more effective
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/806245
Start date: 01-06-2018
End date: 31-05-2022
Total budget - Public funding: 2 082 375,00 Euro - 1 457 662,00 Euro
Cordis data

Original description

The overall objective of the RETINAL initiative of ULMA Embedded Solutions is to develop non-invasive and cost-effective tools with capacity for prevention and/or early detection of various diseases related to NCD complications, by analyzing the changes in the microvasculature of the retina.The basic framework of RETINAL is a comprehensive solution for ophthalmic imaging analysis and treatment composed of a simple, reliable and cost-effective color fundus digital image capture device and several specific software modules associated to the device for a number of specific clinical applications.The goal of this action is to demonstrate in the market, by independent peers, that RETINAL is the best available and cost-effective technology for the detection of diabetic retinopathy in DR Screening Programmes, and particularly valuable for its implementation at primary health centres, which makes screening more accessible to patients and therefore more effectiveThe overall objective of the RETINAL initiative of ULMA Embedded Solutions is to develop non-invasive and cost-effective tools with capacity for prevention and/or early detection of various diseases related to NCD complications, by analyzing the changes in the microvasculature of the retina.The basic framework of RETINAL is a comprehensive solution for ophthalmic imaging analysis and treatment composed of a simple, reliable and cost-effective color fundus digital image capture device and several specific software modules associated to the device for a number of specific clinical applications.The goal of this action is to demonstrate in the market, by independent peers, that RETINAL is the best available and cost-effective technology for the detection of diabetic retinopathy in DR Screening Programmes, and particularly valuable for its implementation at primary health centres, which makes screening more accessible to patients and therefore more effective

Status

CLOSED

Call topic

SMEInst-01-2016-2017

Update Date

27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
H2020-EU.2.1.1.0. INDUSTRIAL LEADERSHIP - ICT - Cross-cutting calls
H2020-SMEINST-1-2016-2017
SMEInst-01-2016-2017 Open Disruptive Innovation Scheme
H2020-SMEINST-2-2016-2017
SMEInst-01-2016-2017 Open Disruptive Innovation Scheme
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-1-2016-2017
SMEInst-01-2016-2017 Open Disruptive Innovation Scheme
H2020-SMEINST-2-2016-2017
SMEInst-01-2016-2017 Open Disruptive Innovation Scheme